Jefferies Group LLC Beyond Spring Inc. Transaction History

Jefferies Group LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$4.02 - $16.84 $86,836 - $363,760	-21,601 Closed	0 $0
Q3 2021 Sep 21, 2023	BUY	$9.26 - $31.31 $200,025 - $676,327	21,601 New	21,601 $340,000
Q3 2021 Nov 15, 2021	SELL	$9.26 - $31.31 $1.22 Million - $4.14 Million	-132,245 Reduced 85.96%	21,601 $340,000
Q2 2020 Aug 14, 2020	BUY	$11.21 - $18.15 $1.72 Million - $2.79 Million	153,846 New	153,846 $2.32 Million

5.44M

30.3K

1.8K

Ticker BYSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,928,900
Market Cap $91.9M
Description
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.